Applications and Challenges of Neoantigen Peptides in Personalized Cancer Vaccines
11-20-2024 Dr. Shan She Senior Global Product Manager, GenScript Biotech Corporation
Multi-transmembrane proteins, especially G-protein coupled receptors (GPCRs), are extremely difficult to develop antibodies against due to their low expression levels, insolubility in vitro, unstable purification and difficulty in maintaining their native
05-10-2024 Dr. Tingting Xiao, Antibody Senior Scientist, GenScript
GMP, the full name is Good Manufacturing Practice, is an independent management system that pays special attention to the quality and health safety of products in the manufacturing process.
03-05-2024 Dr. Guangrui Zhang, Senior Project Manager, GMP project management Department
As one of the most effective peptide modification strategies, cyclization imparts distinct biochemical and therapeutic properties to peptides for drug development, such as increased half-life and cell permeability.
12-07-2023 Dr. Mina Wang, Senior Peptide Scientist, R&D Department, GenScript Biotech
Discover new antimicrobial treatments focusing on AMPs with BioSAXS in our upcoming webinar. Dr. Kai will cover peptide synthesis, screening with spot synthesis on cellulose, and how BioSAXS can classify antimicrobials by mode of action.
03-27-2023 Dr. Kai Hilpert, Associate Professor, St George's, University of London Founder and Director, TiKa Diagnostics
Learn the applications of neoantigen peptides as personalized Cancer Vaccine (PCV), solid tumor immuno-therapy, and the solutions for neoantigen production, through GenScript’s proprietary technologies, for precision immunotherapy development.
12-07-2022 Gracie Chia, Field Application Scientist, GenScript